Azitra is trading at $0.12, down 10.85%, and no clear catalyst has been identified.
- No company announcement dated October 12 explaining the decline was found.
- Azitra’s latest identified company news was its October 1 update that ATR-04 could proceed to Cohort 2 after a safety review.
- The broader market was mixed, so the available evidence does not establish a market-wide explanation for Azitra’s drop.